Biotronik Itrevia 7 HF-T resynchronisation therapy defibrillator approved in Japan for full-body MRI scanning


The Itrevia 7 HF-T cardiac resynchronisation therapy defibrillator (CRT-D) from Biotronik has been approved for full-body magnetic resonance imaging (MRI) scanning in Japan.

The Japanese launch of the device took place in July 2015. This is the first and only CRT-D in Japan with such conditions, according to a company release. All already implanted devices have been deemed safe for full-body MRI scans at 1.5 tesla strength.

Seiji Takatsuki, associate professor of Cardiovascular Medicine at Keio University Hospital, says the announcement marks a leap in treating CRT-D patients with comorbidities. “Until now, cardiac MRI after CRT-D implantation was not possible, thus no assessment on the presence or absence of any changes could be achieved. Now with the condition change, post-operative cardiac MRI examination has become feasible.”